Omeprazole vs ranitidine
Pro Research Analysisby 
Searched over 200M research papers
Omeprazole vs Ranitidine: Efficacy in Treating Acid-Related Disorders
Duodenal and Gastric Ulcer Healing: Omeprazole vs Ranitidine
Multiple studies show that omeprazole is generally more effective than ranitidine in healing duodenal and gastric ulcers. In patients with duodenal ulcers, omeprazole led to higher healing rates at both 2 and 4 weeks compared to ranitidine, and patients experienced faster pain relief and used fewer antacids with omeprazole . For benign gastric ulcers, omeprazole at both 20 mg and 40 mg doses resulted in higher healing rates at 4 and 8 weeks compared to ranitidine, and symptoms were relieved more quickly with omeprazole . In a smaller study, both drugs were effective, but omeprazole appeared superior in healing resistant ulcers .
Gastroesophageal Reflux Disease (GERD) and Reflux Esophagitis: Symptom Relief and Healing
For patients with GERD or reflux esophagitis, omeprazole consistently outperformed ranitidine in both symptom relief and mucosal healing. In patients with persistent GERD symptoms after ranitidine, omeprazole provided faster and more complete symptom resolution and higher rates of endoscopic healing than continued ranitidine or ranitidine combined with metoclopramide . In cases of resistant reflux esophagitis, omeprazole achieved higher healing rates and more rapid symptom relief than high-dose ranitidine, with 63% healed after 4 weeks on omeprazole versus 17% on ranitidine, and this difference persisted through 12 weeks . In children with severe reflux esophagitis, high-dose ranitidine and omeprazole were similarly effective for healing and symptom relief, though both significantly reduced acid exposure .
NSAID-Associated Ulcers: Healing and Prevention
In patients requiring ongoing NSAID therapy, omeprazole was more effective than ranitidine in healing and preventing ulcers. At 8 weeks, about 80% of patients on omeprazole had successful treatment compared to 63% on ranitidine. During maintenance therapy, more patients remained in remission with omeprazole than with ranitidine, and both drugs were well tolerated .
Long-Term Maintenance and Prevention of Relapse
For long-term maintenance in reflux esophagitis, omeprazole was superior to ranitidine in preventing relapse. After 12 months, a higher proportion of patients remained in remission with omeprazole (both 10 mg and 20 mg daily) compared to ranitidine . Another study found that daily omeprazole was much more effective than either weekend omeprazole or daily ranitidine in preventing relapse over a year . In the prevention of benign esophageal stricture recurrence, omeprazole reduced the need for redilatation and provided better symptom relief than ranitidine .
Safety and Tolerability
Both omeprazole and ranitidine were generally well tolerated across studies, with few adverse events reported. The addition of metoclopramide to ranitidine increased adverse events, but omeprazole and ranitidine alone had similar safety profiles Lundell1990Yeomans1998Richter1996+2 MORE.
Conclusion
Overall, omeprazole is more effective than ranitidine for healing and preventing recurrence of ulcers, providing symptom relief in GERD and reflux esophagitis, and maintaining remission in long-term therapy. Both medications are generally safe, but omeprazole offers faster and more complete relief for most acid-related disorders Lundell1990Yeomans1998Mcfarland1990+7 MORE.
Sources and full results
Most relevant research papers on this topic